Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
This chapter will:
Discuss the pathophysiology, diagnosis, and treatment of spontaneous bacterial peritonitis.
Discuss prevention of acute kidney injury and hepatorenal syndrome in patients with spontaneous bacterial peritonitis.
Discuss the management of hepatorenal syndrome in the setting of spontaneous bacterial peritonitis.
Patients with cirrhosis and ascites have a high risk of developing bacterial infections and sepsis compared with the general population, and the development of a bacterial infection has been associated with a fourfold increase in mortality risk in patients with cirrhosis. Among infections, spontaneous bacterial peritonitis (SBP) is one of the most frequent and life threatening in these patients. SBP is defined as a bacterial infection of ascitic fluid developed in patients without any intraabdominal, surgically treatable source of infection. SBP is the second most common infection in hospitalized patients with cirrhosis and ascites, with an incidence of approximately 20%. Approximately 25% of the episodes of SBP are present at the time of hospital admission, and the remainder are acquired during hospitalization.
A pathologic bacterial translocation (BT) from intestinal lumen to mesenteric lymph node is the main character in the pathogenesis of SBP. This “pathologic BT” in cirrhosis is related to several factors, including quantity and quality of intestinal bacteria, increased intestinal permeability, and systemic and local defects in host immunity. The intestinal bacterial overgrowth plays a key role in BT in cirrhosis. It is the result, at least partly, of decreased small-bowel motility and the delayed intestinal transit. Autonomic dysfunction, increased nitric oxide (NO) synthesis, and the oxidative stress of the mucosa are the main causes for decreased intestinal motility. In patients with cirrhosis there is not only an increase in quantity of bacteria in the bowel but also a change in quality. In fact, a depletion of the beneficial phyla Lachnospiraceae and enrichment in the phyla Proteobacteria (mainly Enterobacteriaceae) and Enterococcaceae have been demonstrated in the microbiota of patients with cirrhosis. Interestingly, Enterobacteriaceae (e.g., Escherichia coli, Klebsiella pneumoniae ) and Enterococcaceae have been found to be the most adept at translocating from intestinal lumen to mesenteric lymph node, and they are the pathogens most frequently found in patients with SBP.
Patients with cirrhosis also demonstrate an alteration in the integrity of intestinal mucosal barrier. In fact, portal hypertension leads to ultrastructural changes of intestinal mucosa, such as widening of intracellular spaces, vascular congestion, wall thickening, and tight junctions disruption. These alterations lead to an increased intestinal permeability that facilitates pathologic bacterial translocation.
Finally, alteration of innate and acquired immunity has been observed in patients with cirrhosis. The detailed description of the alterations of immune response in cirrhosis is beyond the purpose of this chapter, but it plays a significant role in the development of SBP because of a lack of control of bacterial translocation.
Patients with SBP may have classic symptoms of infections, such as fever, abdominal pain, and ileus, and lab data may show leukocytosis and an increase in acute phase protein ( Box 84.1 ). However, sometimes the clinical scenario may be more complex without clear signs of infection, and the appearance of hepatic encephalopathy, difficult to control ascites, and/or acute kidney injury (AKI) may be the only clinical signs of SBP. Thus a diagnostic paracentesis should be performed in all patients with ascites admitted for an acute decompensation of cirrhosis. SBP is diagnosed when polymorphonuclear (PMN) cells in ascitic fluid are higher than 250 cells/µL. In all patients, ascitic and blood samples should be collected for microbiologic cultures. Ascitic fluid should be inoculated at the bedside, using blood culture bottles, including aerobic and anaerobic media. Despite the use of sensitive methods, ascites cultures are negative in 60% of cases.
Signs and/or symptoms of systemic inflammation:
Hyper/hypothermia
Chills
Altered WBC count
Tachycardia
Tachypnea
Septic shock
Symptoms and/or signs of peritonitis:
Abdominal pain
Abdominal tenderness
Vomiting
Diarrhea
Ileus
Worsening of liver function (e.g., development of hepatic encephalopathy)
Renal failure:
Hepatorenal syndrome
Acute tubular necrosis
Prerenal failure
Gastrointestinal bleeding
WBC, White blood cell.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here